Mantle cell lymphoma disguised as marginal zone lymphoma

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 7, 2005, Pages 929-932

  Jacobson, Erica ^a,c   Burke, Peter ^b   Tindle, Barbara H ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Northwestern Medical Center   (United States)

^c FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; RITUXIMAB;

AGED; ARTICLE; ASPIRATION BIOPSY; B CELL LYMPHOMA; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LUNG ADENOCARCINOMA; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; PERCUTANEOUS BIOPSY; SPINE METASTASIS; STOMACH ADENOCARCINOMA;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; MALE;

EID: 21344460222     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood. 1996;87:4483-4494.
2. Armitage JO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
3. Swerdlow SH, Berger F, Isaacson PI, et al. Mantle cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France; IARC Press; 2001:168-170.
4. World Health Organization Classification of Tumours; vol 3.
5. Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992;16:637-640.
6. Pittaluga S, Wlodarska I, Stul MS, et al. Mantle cell lymphoma: a clinicopathologic study of 55 cases. Histopathology. 1995;26:17-24.
7. Argatoff LH, Connors LM, Klasa RJ, Horsman DE, Cascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067-2078.
8. Swerdlow SH, Zukerberg LR, Yang WY, Harris NL, Williams ME. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Am J Surg Pathol. 1996;20:627-640.
9. Yatabe Y, Suzuki R, Matsuno Y, et al. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases. Pathol Int. 2001;51:747-761.
10. Majlis A, Pugh WC, Rodriguez MA, Benedict WF, Cabanillas F. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol. 1997;15:1664-1671.
11. Weisenburger DD. Mantle cell lymphoma. In: Knowles DM, ed. Neoplastic Hematopathology. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:789-803.
12. Hoffmann DC, Tucker SJ, Emmanoulides C, et al. CD8-positive mantle cell lymphoma: a report of 2 cases. Am J Clin Pathol. 1998;109:689-694.
13. Bosch F, Jares P, Campo E, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood. 1994;84:2726-2732.
14. Yatabe Y, Nakamura S, Seto M, et al. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma: a distinct molecular pathologic entity. Am J Surg Pathol. 1996;20:1110-1122.
15. Oka K, Ohno T, Kita K, et al. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol. 1994;86:786-791.
16. Anagnostopoulos I, Foss H-D, Hummel M, Trenn C, Stein H. Extranodal mantle cell lymphoma mimicking marginal zone cell lymphoma. Histopathology. 2001;39:561-565.